Cher-Ming Liou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cher-Ming Liou has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ann Yi-Chiun Chuang
Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan
1 shared publication Chiehfeng Chen
Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan
1 shared publicationHon-Kit Lau
Department of Anesthesiology, Chung Shan Medical University Hospital, Institute of Medicine, Chung Shan Medical University, Taichung 407, Taiwan
1 shared publicationHsin-Ming Liu
Department of Ophthalmology, Mackay Memorial Hospital, No. 92, Sec. 2, Zhongshan N. Rd., Zhongshan Dist., Taipei City, Taiwan; Cochrane Taiwan, Taipei Medical University, No. 250, Wu-Hsing Street, Taipei City, Taiwan
1 shared publication- Hsin-Ming Liu
Department of Ophthalmology, Mackay Memorial Hospital, Taipei, Taiwan; and
1 shared publication Jin-Hua Chen
Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan
1 shared publication
Latest Publications
- 20 July 2025
- Published by Elsevier in Contact Lens and Anterior Eye
- Vol. 48 (6) , 102477
Therapeutic effect of intense pulsed light in ocular demodicosis: A systematic review and meta-analysis
- 20 July 2025
- Published by Elsevier in Contact Lens and Anterior Eye
- Vol. 48 (6) , 102477
Therapeutic effect of intense pulsed light in ocular demodicosis: A systematic review and meta-analysis
- 13 January 2021
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 43 (3) , 476-485
Prophylactic antiemetic effects of dexamethasone versus 5-HT3 receptor antagonists in ear surgery: a systematic review and meta-analysis
Background The optimal strategy for reducing the high incidence of postoperative nausea and vomiting (PONV) after otologic surgical procedures remains inconclusive. Aim of the review This study compared the prophylactic antiemetic effects of dexamethasone with 5-hydroxytryptamine 3 receptor antagonists (5-HT3-RAs) in ear surgery. Method PubMed, Embase, and Cochrane Library were searched up to October 31, 2020 for randomized controlled trials that used dexamethasone either singly or in combination with 5-HT3-RAs for PONV prophylaxis in adults undergoing ear surgery. Studies in languages other than English and those without a control group of 5-HT3-RAs were excluded. Random effects meta-analyses were performed, and risk of bias was assessed using the version 2 of the Cochrane risk-of-bias tool. Main outcome measures include incidences of early (< 6 h) and overall (0–48 h) PONV, the overall requirement for rescue antiemetics, and the occurrence of adverse events. Results Eight trials of 733 adults were included, and the overall risks of bias were generally low. Pooled risk ratios (RRs) of early and overall PONV of dexamethasone versus 5-HT3-RAs were 2.0 (95% CI 0.8–5.1, I2 = 82%), and 1.3 (95% CI 0.6–2.6, I2 = 86%). In studies comparing dexamethasone plus 5-HT3-RAs with 5-HT3-RAs alone, pooled RRs of early and overall PONV were 0.8 (95% CI 0.4–1.4, I2 = 30%), and 0.5 (95% CI 0.3–0.6, I2 = 0%), respectively. Pooled RRs of the overall need for rescue antiemetics comparing 5-HT3-RAs with dexamethasone alone and in combination with 5-HT3-RAs were 1.2 (95% CI 0.4–3.9, I2 = 73%) and 0.4 (95% CI 0.1–1.4, I2 = 61%), respectively. Common adverse events reported were headache and dizziness, and the incidences range from 0 to 10% without significant differences between the groups. Conclusion The prophylactic antiemetic effects of dexamethasone versus 5-HT3-RAs in ear surgery did not significantly differ in the early and overall postoperative phases. The combination of dexamethasone with 5-HT3-RAs showed superior overall PONV prophylactic effects to 5-HT3-RAs alone in ear surgery, but their differences in the need for rescue antiemetics remained non-significant.
- 13 January 2021
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 43 (3) , 476-485
Prophylactic antiemetic effects of dexamethasone versus 5-HT3 receptor antagonists in ear surgery: a systematic review and meta-analysis
Background The optimal strategy for reducing the high incidence of postoperative nausea and vomiting (PONV) after otologic surgical procedures remains inconclusive. Aim of the review This study compared the prophylactic antiemetic effects of dexamethasone with 5-hydroxytryptamine 3 receptor antagonists (5-HT3-RAs) in ear surgery. Method PubMed, Embase, and Cochrane Library were searched up to October 31, 2020 for randomized controlled trials that used dexamethasone either singly or in combination with 5-HT3-RAs for PONV prophylaxis in adults undergoing ear surgery. Studies in languages other than English and those without a control group of 5-HT3-RAs were excluded. Random effects meta-analyses were performed, and risk of bias was assessed using the version 2 of the Cochrane risk-of-bias tool. Main outcome measures include incidences of early (< 6 h) and overall (0–48 h) PONV, the overall requirement for rescue antiemetics, and the occurrence of adverse events. Results Eight trials of 733 adults were included, and the overall risks of bias were generally low. Pooled risk ratios (RRs) of early and overall PONV of dexamethasone versus 5-HT3-RAs were 2.0 (95% CI 0.8–5.1, I2 = 82%), and 1.3 (95% CI 0.6–2.6, I2 = 86%). In studies comparing dexamethasone plus 5-HT3-RAs with 5-HT3-RAs alone, pooled RRs of early and overall PONV were 0.8 (95% CI 0.4–1.4, I2 = 30%), and 0.5 (95% CI 0.3–0.6, I2 = 0%), respectively. Pooled RRs of the overall need for rescue antiemetics comparing 5-HT3-RAs with dexamethasone alone and in combination with 5-HT3-RAs were 1.2 (95% CI 0.4–3.9, I2 = 73%) and 0.4 (95% CI 0.1–1.4, I2 = 61%), respectively. Common adverse events reported were headache and dizziness, and the incidences range from 0 to 10% without significant differences between the groups. Conclusion The prophylactic antiemetic effects of dexamethasone versus 5-HT3-RAs in ear surgery did not significantly differ in the early and overall postoperative phases. The combination of dexamethasone with 5-HT3-RAs showed superior overall PONV prophylactic effects to 5-HT3-RAs alone in ear surgery, but their differences in the need for rescue antiemetics remained non-significant.
- 1 June 2010
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 22 (4) , 237-240
Retrospective analysis of surgery postponed or cancelled in the operating room
- 1 June 2010
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 22 (4) , 237-240
Retrospective analysis of surgery postponed or cancelled in the operating room